Stay updated on Belantamab vs Daratumumab in Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the Belantamab vs Daratumumab in Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Belantamab vs Daratumumab in Multiple Myeloma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The record’s administrative details were refreshed, including updated last-update dates, revision/version information, and an updated EU trial identifier. The listed number and geographic distribution of participating locations were also adjusted (with some sites removed and new/updated site entries added).
    Difference
    4%
    Check dated 2026-04-27T07:43:19.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2. Removed the topics 'Multiple myeloma' and 'MedlinePlus Genetics' (related topics) and the older 'Revision: v3.5.0' entry from the page's topic/list metadata.
    Difference
    0.1%
    Check dated 2026-04-20T03:57:58.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    Added related topics: Multiple myeloma and MedlinePlus Genetics to the related topics section. No core content or functionality of the study page was changed.
    Difference
    0.1%
    Check dated 2026-04-05T19:27:13.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    Added the updated DREAMM-7 publication citation (Lancet Oncology 2025) with the updated overall survival analysis and related erratum details, replacing the prior entry.
    Difference
    0.0%
    Check dated 2026-03-22T08:59:53.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added and Revision: v3.4.2 was removed from the page.
    Difference
    0.0%
    Check dated 2026-03-07T19:56:05.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    Added a new publication reference for DREAMM-7 updated overall survival in Lancet Oncol (2025) to the Publications section. Removed the disease keyword 'Multiple myeloma' and related topics from the keywords/related topics.
    Difference
    0.1%
    Check dated 2026-02-21T12:48:58.000Z thumbnail image

Stay in the know with updates to Belantamab vs Daratumumab in Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Belantamab vs Daratumumab in Multiple Myeloma Clinical Trial page.